0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

MUMPS: USE OF CONVALESCENT SERUM IN THE TREATMENT AND PROPHYLAXIS OF ORCHITIS

ALWIN C. RAMBAR, M.D.
Am J Dis Child. 1946;72(6):761. doi:10.1001/archpedi.1946.02020350128012.
Text Size: A A A
Published online

ABSTRACT

To the Editor:—Doctor Paychère's results in reducing the incidence of orchitis in adolescents and adults to zero are most interesting, although they are different from my own and from those of Haerem and others.

I have used sulfonamide compounds in the treatment of mumps orchitis, although the records of these patients are not now available. My recollection, however, is definitely that no noticeable benefit resulted. I doubt that the use of sulfonamide drugs parenterally would have produced results any different from those obtained by oral administration.

There are several reports in the literature of the use of the sulfonamide compounds in the treatment and prevention of orchitis. Haerem, in the Military Surgeon92:306-312, March 1943, treated 500 patients with mumps, dividing his groups so that 100 were controls, 100 each were treated with sulfathiazole, sulfapyridine and sulfanilamide, and 100 were given convalescent serum. His conclusions were that the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();